Sequencing, Sustainability Are Hot Topics in CAR T- and Gene Cell Therapies Discussion
AJMC,
With approvals for bispecific antibodies coming in the weeks before and after the 11th Annual Patient-Centered Oncology Care®…
Long-Term (≥4 Year and ≥5 Year) Overall Survival (OS) By 12- and 24-Month Event-Free Survival (EFS): An Updated Analysis of ZUMA-1, the Pivotal Study of Axicabtagene Ciloleucel (Axi-Cel) in Patients (P…
Overview of attention for article published in Blood, November 2021
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (90th percentile)
-
High Attention Score compared to outputs of the same age and source (93rd percentile)
Readers on
- mendeley
- 36 Mendeley
